|Articles|February 1, 2016
- BioPharm International-02-01-2016
- Volume 28
- Issue 2
BioPharm International, February 2016 Issue (PDF)
Click the title above to open the BioPharm International February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Antibody Production in Microbial Hostsover 9 years ago
Advances in Assay Technologies for CAR T-Cell Therapiesover 9 years ago
Innovative Therapies Require Modern Manufacturing Systemsover 9 years ago
Macro Mattersover 9 years ago
Fine Tuning the Focus on Biopharma Analytical Studiesover 9 years ago
Biopharma Innovation Born Again?over 9 years ago
Failure Mode Effects Analysis for Filter Integrity Testingover 9 years ago
The Emerging View of Endotoxin as an IIRMIover 9 years ago
Use of an E. coli pgi Knockout Strain as a Plasmid ProducerNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
